Streetbeat News

Price Targets

HBM

Jefferies analyst Matthew Murphy has upgraded Hudbay Minerals (TSX:HBM) from Hold to Buy and set a price target of C$14.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:23 am

NRIX

Oppenheimer analyst Mark Breidenbach maintains an Outperform rating on Nurix Therapeutics (NASDAQ:NRIX) and raises the price target from $25 to $27.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:22 am

JXN

Keefe, Bruyette & Woods analyst Ryan Krueger maintains a Market Perform rating on Jackson Financial (NYSE:JXN) and raises the price target from $80 to $82.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:20 am

KZR

HC Wainwright & Co. has reiterated its Buy rating on Kezar Life Sciences (NASDAQ:KZR) and maintained a price target of $7.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:18 am

BHF

Keefe, Bruyette & Woods analyst Brett Osetec maintains a Market Perform rating on Brighthouse Financial (NASDAQ:BHF) but lowers the price target from $47 to $43.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:18 am

TBNK

Keefe, Bruyette & Woods analyst Kelly Motta maintains a Market Perform rating on Territorial Bancorp (NASDAQ:TBNK) and raises the price target from $9.66 to $11.27.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:16 am

HG

Keefe, Bruyette & Woods analyst Thomas McJoynt-Griffith maintains an Outperform rating on Hamilton Insurance Group (NYSE:HG) and raises the price target from $21 to $22.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:14 am

URGN

HC Wainwright & Co. has reiterated its Buy rating on UroGen Pharma (NASDAQ:URGN) and maintained a price target of $60.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:14 am

AIZ

Keefe, Bruyette & Woods analyst Thomas McJoynt-Griffith maintains a Market Perform rating on Assurant (NYSE:AIZ) and raises the price target from $186 to $194.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:12 am

WULF

Rosenblatt analyst Kevin Cassidy maintains a Buy rating on TeraWulf (NASDAQ:WULF) and raises the price target from $4.2 to $5.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:11 am